Clearbridge Biomedics

Clearbridge Biomedics

Medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.

Launch date
Employees
Market cap
-
Enterprise valuation
$26—38m (Dealroom.co estimates Mar 2013.)
Singapore Singapore (HQ)
  • Edit
DateInvestorsAmountRound

SGD8.7m

Series B
Total Funding$6.4m

Recent News about Clearbridge Biomedics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.